DE602004001395D1 - Rhesus-karzinoembryonales antigen, dieses codierende nukleotide und verwendungen davon - Google Patents

Rhesus-karzinoembryonales antigen, dieses codierende nukleotide und verwendungen davon

Info

Publication number
DE602004001395D1
DE602004001395D1 DE602004001395T DE602004001395T DE602004001395D1 DE 602004001395 D1 DE602004001395 D1 DE 602004001395D1 DE 602004001395 T DE602004001395 T DE 602004001395T DE 602004001395 T DE602004001395 T DE 602004001395T DE 602004001395 D1 DE602004001395 D1 DE 602004001395D1
Authority
DE
Germany
Prior art keywords
cea
rhcea
antigen
development
rhesus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE602004001395T
Other languages
English (en)
Other versions
DE602004001395T2 (de
Inventor
Luigi Aurisicchio
Gennaro Ciliberto
Armin Lahm
Monica Nicola La
Paolo Monaci
Fabio Palombo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Original Assignee
Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto di Ricerche di Biologia Molecolare P Angeletti SpA filed Critical Istituto di Ricerche di Biologia Molecolare P Angeletti SpA
Publication of DE602004001395D1 publication Critical patent/DE602004001395D1/de
Application granted granted Critical
Publication of DE602004001395T2 publication Critical patent/DE602004001395T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00118—Cancer antigens from embryonic or fetal origin
    • A61K39/001182—Carcinoembryonic antigen [CEA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3007—Carcino-embryonic Antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5256—Virus expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE602004001395T 2003-02-13 2004-02-09 Rhesus-karzinoembryonales antigen, dieses codierende nukleotide und verwendungen davon Expired - Fee Related DE602004001395T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US44720303P 2003-02-13 2003-02-13
US447203P 2003-02-13
PCT/EP2004/001181 WO2004072287A1 (en) 2003-02-13 2004-02-09 Rhesus carcino embryonic antigen, nucleotides encoding same, and uses thereof

Publications (2)

Publication Number Publication Date
DE602004001395D1 true DE602004001395D1 (de) 2006-08-10
DE602004001395T2 DE602004001395T2 (de) 2007-08-09

Family

ID=32869610

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004001395T Expired - Fee Related DE602004001395T2 (de) 2003-02-13 2004-02-09 Rhesus-karzinoembryonales antigen, dieses codierende nukleotide und verwendungen davon

Country Status (9)

Country Link
US (1) US20060228335A1 (de)
EP (1) EP1597370B1 (de)
JP (1) JP2006518202A (de)
AT (1) ATE331796T1 (de)
AU (1) AU2004211481A1 (de)
CA (1) CA2514969A1 (de)
DE (1) DE602004001395T2 (de)
ES (1) ES2267046T3 (de)
WO (1) WO2004072287A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005019455A1 (en) * 2003-08-22 2005-03-03 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof
ES2387850T3 (es) * 2004-02-11 2012-10-02 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.R.L. Proteína de fusión al antígeno carcinoembrionario y sus usos
CA2607056C (en) * 2005-10-19 2015-11-24 Ibc Pharmaceuticals, Inc. Methods and compositions for generating bioactive assemblies of increased complexity and uses

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5274087A (en) * 1986-08-13 1993-12-28 Molecular Diagnostics, Inc. cDNA coding for carcinoembryonic antigen (CEA)
ES2206446T3 (es) * 1991-05-06 2004-05-16 The Government Of The Usa As Represented By The Secretary Of Department Of Health And Human Services Virus recombinante que expresa un antigeno carcinoembrionico y metodos de uso del mismo.
ATE391726T1 (de) * 1999-10-22 2008-04-15 Sanofi Pasteur Ltd Modifiziertes gp100 und dessen verwendung
WO2005019455A1 (en) * 2003-08-22 2005-03-03 Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa Synthetic gene encoding rhesus monkey carcinoembryonic antigen and uses thereof

Also Published As

Publication number Publication date
DE602004001395T2 (de) 2007-08-09
AU2004211481A1 (en) 2004-08-26
ES2267046T3 (es) 2007-03-01
CA2514969A1 (en) 2004-08-26
ATE331796T1 (de) 2006-07-15
EP1597370B1 (de) 2006-06-28
EP1597370A1 (de) 2005-11-23
JP2006518202A (ja) 2006-08-10
WO2004072287A1 (en) 2004-08-26
US20060228335A1 (en) 2006-10-12

Similar Documents

Publication Publication Date Title
EP1716173B8 (de) Fusionsproteine des karzinomembryonalen antigens und deren verwendungen
NO20055708L (no) Syntetisk gen som koder for humant karsinembryonalt antigen og anvendelser derav
NO20060813L (no) Syntetisk gen som koder for human epidermalvekstfaktor 2/NEU og andvendelser derav
ATE534661T1 (de) Fusionsprotein aus telomerase und reverser transkriptase, dafür codierende nukleotide und anwendungen davon
IL226717A (en) Isolated nucleic acids encoded by anti-beta human antibodies 7
SG170080A1 (en) Human monoclonal antibodies to o8e
UA92580C2 (ru) Антитело, которое специфически связывается с cd22, и его терапевтическое и диагностическое применение
CY1108478T1 (el) Ιος της ομαδας pox με στοχοθετημενη ειδικοτητα μολυνσης
WO2000031235A3 (en) Nucleotide and protein sequences of nogo genes and methods based thereon
MXPA05008794A (es) Antigeno de glicoproteina sima135 expresado en celulas tumorales humanas metastasicas.
TW200607524A (en) A fusion protein for inhibiting cervical cancer
BR9915969A (pt) Toxinas pesticidas e seq ências de nucleotìdeos que codificam estas toxinas
WO2005053604A3 (en) Antibodies specific for cancer associated antigen sm5-1 and uses thereof
DE602004001395D1 (de) Rhesus-karzinoembryonales antigen, dieses codierende nukleotide und verwendungen davon
GB0418388D0 (en) Cell therapy
HUP0104825A2 (hu) Gének, fehérjék és alkalmazásuk
WO2003055908A3 (en) Bag3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases
NZ334839A (en) Polynucleotide molecules encoding neospora proteins and uses thereof
Hatzi et al. B-cell chronic lymphocytic leukemia (B-CLL) cells express antibodies reactive with antigenic epitopes expressed on the surface of common bacteria.
WO2003084996A3 (en) Anti-idiotype anti-cea antibody molecules and its use as cancer vaccine
WO2023078386A8 (zh) 抗cldn18.2抗体及其用途
WO2004015098A3 (en) Rhesus epithelial cell adhesion molecule, nucleic acid encoding the same, and uses thereof
JP2007511534A5 (de)
MX2023012707A (es) Anticuerpos de la proteina inmunorreceptora de celulas t con dominios ig e itim (anti-tigit) y metodos de uso de estos.
SG148195A1 (en) Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee